These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37197827)

  • 1. Phage-Displayed SH2 Domain Libraries: From Ultrasensitive Tyrosine Phosphoproteome Probes to Translational Research.
    Martyn GD; Veggiani G
    Cold Spring Harb Protoc; 2024 May; 2024(5):107981. PubMed ID: 37197827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered SH2 domains with tailored specificities and enhanced affinities for phosphoproteome analysis.
    Veggiani G; Huang H; Yates BP; Tong J; Kaneko T; Joshi R; Li SSC; Moran MF; Gish G; Sidhu SS
    Protein Sci; 2019 Feb; 28(2):403-413. PubMed ID: 30431205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of natural ligands for SH2 domains from a phage display cDNA library.
    Cochrane D; Webster C; Masih G; McCafferty J
    J Mol Biol; 2000 Mar; 297(1):89-97. PubMed ID: 10704309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superbinder SH2 domains act as antagonists of cell signaling.
    Kaneko T; Huang H; Cao X; Li X; Li C; Voss C; Sidhu SS; Li SS
    Sci Signal; 2012 Sep; 5(243):ra68. PubMed ID: 23012655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered SH2 Domains for Targeted Phosphoproteomics.
    Martyn GD; Veggiani G; Kusebauch U; Morrone SR; Yates BP; Singer AU; Tong J; Manczyk N; Gish G; Sun Z; Kurinov I; Sicheri F; Moran MF; Moritz RL; Sidhu SS
    ACS Chem Biol; 2022 Jun; 17(6):1472-1484. PubMed ID: 35613471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.
    Bradshaw JM; Mitaxov V; Waksman G
    J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent inhibitory ligands of the GRB2 SH2 domain from recombinant peptide libraries.
    Hart CP; Martin JE; Reed MA; Keval AA; Pustelnik MJ; Northrop JP; Patel DV; Grove JR
    Cell Signal; 1999 Jun; 11(6):453-64. PubMed ID: 10400318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-O-(2-malonyl)tyrosine: a new phosphotyrosyl mimetic for the preparation of Src homology 2 domain inhibitory peptides.
    Ye B; Akamatsu M; Shoelson SE; Wolf G; Giorgetti-Peraldi S; Yan X; Roller PP; Burke TR
    J Med Chem; 1995 Oct; 38(21):4270-5. PubMed ID: 7473554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel non-phosphorylated ligands, which bind selectively to the SH2 domain of Grb7.
    Pero SC; Oligino L; Daly RJ; Soden AL; Liu C; Roller PP; Li P; Krag DN
    J Biol Chem; 2002 Apr; 277(14):11918-26. PubMed ID: 11809769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of phosphopeptide ligands for the Src-homology 2 (SH2) domain of Grb2 by phage display.
    Gram H; Schmitz R; Zuber JF; Baumann G
    Eur J Biochem; 1997 Jun; 246(3):633-7. PubMed ID: 9219519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of Src Homology 2 (SH2) Domain to Recognize Sulfotyrosine.
    Ju T; Niu W; Guo J
    ACS Chem Biol; 2016 Sep; 11(9):2551-7. PubMed ID: 27428792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting the phosphotyrosine binding pocket of Fyn SH2 domain led to the identification of novel SH2 superbinders.
    Li S; Zou Y; Zhao D; Yin Y; Song J; He N; Liu H; Qian D; Li L; Huang H
    Protein Sci; 2021 Mar; 30(3):558-570. PubMed ID: 33314411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of novel affinity reagents for detecting protein tyrosine phosphorylation based on superbinder SH2 domain in tumor cells.
    Ke AQ; Liu AD; Gao YN; Luo DN; Li ZF; Yu YQ; Liu JY; Xu H; Cao X
    Anal Chim Acta; 2018 Nov; 1032():138-146. PubMed ID: 30143211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonphosphorylated peptide ligands for the Grb2 Src homology 2 domain.
    Oligino L; Lung FD; Sastry L; Bigelow J; Cao T; Curran M; Burke TR; Wang S; Krag D; Roller PP; King CR
    J Biol Chem; 1997 Nov; 272(46):29046-52. PubMed ID: 9360978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering SH2 Domains with Tailored Specificities and Affinities.
    Martyn GD; Veggiani G; Sidhu SS
    Methods Mol Biol; 2023; 2705():307-348. PubMed ID: 37668982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP/SH2D1A.
    Li SC; Gish G; Yang D; Coffey AJ; Forman-Kay JD; Ernberg I; Kay LE; Pawson T
    Curr Biol; 1999 Dec; 9(23):1355-62. PubMed ID: 10607564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the binding specificity of the SH2 domains of protein tyrosine phosphatase SHP-1 through the screening of a combinatorial phosphotyrosyl peptide library.
    Beebe KD; Wang P; Arabaci G; Pei D
    Biochemistry; 2000 Oct; 39(43):13251-60. PubMed ID: 11052678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of residues in GTPase-activating protein Src homology 2 domains that control binding to tyrosine phosphorylated growth factor receptors and p62.
    Marengere LE; Pawson T
    J Biol Chem; 1992 Nov; 267(32):22779-86. PubMed ID: 1385407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biphasic Affinity Chromatographic Approach for Deep Tyrosine Phosphoproteome Analysis.
    Deng Z; Dong M; Wang Y; Dong J; Li SS; Zou H; Ye M
    Anal Chem; 2017 Feb; 89(4):2405-2410. PubMed ID: 28192900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-Step SH2 Superbinder-Based Approach for Sensitive Analysis of Tyrosine Phosphoproteome.
    Yao Y; Wang Y; Wang S; Liu X; Liu Z; Li Y; Fang Z; Mao J; Zheng Y; Ye M
    J Proteome Res; 2019 Apr; 18(4):1870-1879. PubMed ID: 30875230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.